Jonathan  Slonin net worth and biography

Jonathan Slonin Biography and Net Worth

Chief Medical Officer of Pacira BioSciences

Dr. Jonathan Slonin joined Pacira in 2020 and most recently served as Chief Clinical Officer, directing the Company’s customer-facing medical operations and iovera device franchise. As Chief Medical Officer, Dr. Slonin will oversee research and development and all customer-facing medical operations in addition to clinical, R&D, and medical strategy. He brings over 15 years of experience to Pacira as a board-certified anesthesiologist who has held numerous clinical and leadership positions with TeamHealth and Envision Healthcare including Regional Medical Director for the Southeast with TeamHealth and Chairman of Anesthesiology for the Cleveland Clinic Martin Health. Dr. Slonin received his Bachelor of Science in Biomedical Engineering and his MD degree from the University of Miami. He completed his anesthesiology residency at University of Miami/Jackson Memorial Hospital where he served as chief resident. Dr. Slonin received his MBA degree from George Washington University.

What is Jonathan Slonin's net worth?

The estimated net worth of Jonathan Slonin is at least $2.32 million as of January 6th, 2025. Dr. Slonin owns 93,444 shares of Pacira BioSciences stock worth more than $2,318,346 as of April 2nd. This net worth evaluation does not reflect any other assets that Dr. Slonin may own. Additionally, Dr. Slonin receives an annual salary of $815,250.00 as Chief Medical Officer at Pacira BioSciences. Learn More about Jonathan Slonin's net worth.

How old is Jonathan Slonin?

Dr. Slonin is currently 49 years old. There are 7 older executives and no younger executives at Pacira BioSciences. The oldest executive at Pacira BioSciences is Mr. David M. Stack, Advisor, who is 74 years old. Learn More on Jonathan Slonin's age.

What is Jonathan Slonin's salary?

As the Chief Medical Officer of Pacira BioSciences, Inc., Dr. Slonin earns $815,250.00 per year. The highest earning executive at Pacira BioSciences is Mr. David M. Stack, Advisor, who commands a salary of $1,540,000.00 per year. Learn More on Jonathan Slonin's salary.

How do I contact Jonathan Slonin?

The corporate mailing address for Dr. Slonin and other Pacira BioSciences executives is 5 SYLVAN WAY SUITE 300, PARSIPPANY NJ, 07054. Pacira BioSciences can also be reached via phone at (813) 553-6680 and via email at susan.mesco@pacira.com. Learn More on Jonathan Slonin's contact information.

Has Jonathan Slonin been buying or selling shares of Pacira BioSciences?

Jonathan Slonin has not been actively trading shares of Pacira BioSciences during the last quarter. Most recently, Jonathan Slonin sold 879 shares of the business's stock in a transaction on Monday, January 6th. The shares were sold at an average price of $18.40, for a transaction totalling $16,173.60. Following the completion of the sale, the insider now directly owns 93,444 shares of the company's stock, valued at $1,719,369.60. Learn More on Jonathan Slonin's trading history.

Who are Pacira BioSciences' active insiders?

Pacira BioSciences' insider roster includes Marcelo Bigal (Director), Mark Froimson (Director), Mark Kronenfeld (Director), Frank Lee (Chief Executive Officer & Director), Donald Manning (Insider), Max Reinhardt (Insider), Charles Reinhart, III (CFO), Lauren Riker (VP), Jonathan Slonin (Chief Medical Officer), David Stack (CEO), Andreas Wicki (Director), Kristen Williams (Insider), Kristen Williams (Chief Administrative Officer & Secretary), and Roy Winston (Insider). Learn More on Pacira BioSciences' active insiders.

Are insiders buying or selling shares of Pacira BioSciences?

In the last twelve months, Pacira BioSciences insiders bought shares 3 times. They purchased a total of 11,176 shares worth more than $136,240.40. In the last twelve months, insiders at the sold shares 10 times. They sold a total of 23,974 shares worth more than $653,601.25. The most recent insider tranaction occured on January, 6th when insider Jonathan Slonin sold 879 shares worth more than $16,173.60. Insiders at Pacira BioSciences own 6.4% of the company. Learn More about insider trades at Pacira BioSciences.

Information on this page was last updated on 1/6/2025.

Jonathan Slonin Insider Trading History at Pacira BioSciences

See Full Table

Jonathan Slonin Buying and Selling Activity at Pacira BioSciences

This chart shows Jonathan Slonin's buying and selling at Pacira BioSciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$100k$0$100kTotal Insider BuyingTotal Insider Selling

Pacira BioSciences Company Overview

Pacira BioSciences logo
Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.
Read More

Today's Range

Now: $24.89
Low: $23.66
High: $24.93

50 Day Range

MA: $24.89
Low: $22.04
High: $27.25

2 Week Range

Now: $24.89
Low: $11.16
High: $31.67

Volume

452,799 shs

Average Volume

937,086 shs

Market Capitalization

$1.15 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.7